Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

79.47
Delayed Data
As of Jul 29
 -1.77 / -2.18%
Today’s Change
77.92
Today|||52-Week Range
120.37
-21.46%
Year-to-Date
Gilead (GILD) Stock Down on Q3 Outlook, Argus Downgrades
Jul 29 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene
Jul 28 / Zacks.com - Paid Partner Content
What Awaits ACUR & Other Drug Stocks this Earnings Season?
Jul 29 / Zacks.com - Paid Partner Content
2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK
Jul 28 / Zacks.com - Paid Partner Content
10 Most Undervalued Companies for the Enterprising Investor - July
Jul 28 / GuruFocus News - Paid Partner Content
Gilead Sciences Is Still a Buy
Jul 27 / GuruFocus News - Paid Partner Content
Research Reports for Facebook, DuPont, Gilead & Others
Jul 28 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure
Jul 27 / Zacks.com - Paid Partner Content
Hep C Business Slow-Down Could Hamper Bristol-Myers' Future
Jul 28 / TheStreet.com - Paid Partner Content
Gilead's Valuation Makes It a Screaming Buy
Jul 27 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close81.24
Today’s open80.60
Day’s range79.37 - 80.84
Volume19,465,672
Average volume (3 months)10,333,403
Market cap$108.9B
Dividend yield2.37%
Data as of 4:14pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-6.54%
Earnings growth (next 5 years)-1.20%
Revenue growth (last year)+28.71%
P/E ratio6.8
Price/Sales4.80
Price/Book6.28

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+0.75+0.44%
BIIBBiogen+0.90+0.31%
BAXBaxter International...-0.20-0.41%
NBIXNeurocrine Bioscienc...+0.08+0.16%
Data as of 4:14pm ET, 07/29/2016

Financials

Last reporting dateJuly 25, 2016
EPS forecast (this quarter)$3.01
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts

Partner Offers

Search for Jobs